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Abstract
Shewanella algae was isolated from the purulent discharge in the
navel area of a young male with a history of swimming in the
Persian Gulf. A routine laboratory diagnosis procedure, followed
by 16S rRNA gene sequence analyses, was used to avoid
misidentification with other species of Shewanella. The bacterium
was suscetible to ceftazidime, ciprofloxacin, nalidixic acid, ni-
trophorantion, amikacin, ceftriaxone, cefotaxime, gentamicin and
co-trimoxazole but was resistant to amoxicillin, vancomycin,
doxycycline, cephalexin, ampicillin, tetracycline, cephalothin and
ceftizoxime. The patient successfully recovered after treatment
with antibiotics.
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Research Note
We report here on a case of wound infection due to
Shewanella algae in the navel area of a patient. A 24-year-old
man was admitted to the MEHR outpatient clinic in Bushehr,
southern Iran, in December 2010 with an infection in his navel
area. A preliminary diagnosis suggested that the patient had a
pilonidal cyst and/or un-shut suture from his neonatal period
which had caused the infection in that area. Interviewing the
patient revealed that a purulent discharge had developed after
he had been swimming in the Persian Gulf, 3 months earlier.
The patient was prescribed a combination of cloxacillin
(500 mg/6 h for a week), cefixime (400 mg/12 h for 5 days)
and ciprofloxacin (500 mg/12 h for a week). The affected area
was also cleaned with 70% alcohol daily but the purulent
discharge did not stop. A swab culture was taken from the
lesion’s exudate and submitted to the pathology laboratory.
Results indicated the pure growth of an organism forming
light-brown mucoid colonies on 5% sheep blood agar. The
organism was subsequently identified as a member of the
S. putrefaciens group with the API 20E system (biomerieux, Inc.,
Hazelwood, MO, USA). Further tests, including hydrogen
sulfide production on TSI slants, growth on media containing
6.5% NaCl and reduction of nitrite [1], identified the organism
as S. algae although the bacterium did not produce b-haemolysis
on sheep blood agar as shown by others [2, 3]. PCR
amplification of the 16S rRNA was performed using the
universal primer pair fD1 and rp2 [4], and sequencing of the
PCR product showed 99% similarity to S. algae.
The bacterium was susceptible to ceftazidime (30 lg),
ciprofloxacin (5 lg), nalidixic acid (30 lg), nitrophorantion
(300 lg), amikacin (30 lg), ceftriaxone (30 lg), cefotaxime
(30 lg), gentamicin (10 lg), co-trimoxazole (trimethoprim
1.25 lg/sulfamethoxazole 23.75 lg) but was resistant to
amoxicillin (30 lg), vancomycin (30 lg), doxycyclin (30 lg),
cephalexin (30 lg), ampicillin (10 lg), tetracycline (30 lg),
cephalothin (30 lg) and ceftizoxime (30 lg).
More than 50 species of Shewanella have been described but
with the exception of the recent case report of S. xiamensis
causing a peripancreatic infection [5], all other reported
illnesses involving the genus Shewanella have been linked to
either S. putrefaciens and S. algae infection with the latter being
more common in clinical cases [1, 5, 6]. These bacteria are found
in marine environments and in countries with warm climates
or during especially warm summers in other countries [1] with
the most common portal of entry being injured skin [6, 7].
The most common clinical syndrome reported in the
literature is infection of the skin and soft tissues [8–10]. It
often occurs in elderly patients with chronic ulcers of the
lower extremities, but soft-tissue infections in healthy subjects
have also been described [10]. Only a few patients will develop
necrotizing fasciitis [7, 11, 12]. Otitis media is mostly found in
children after contact with seawater [2, 13]. Shewanella spp.
have also been reported as pathogens causing intra-abdominal
infections [14]. lower respiratory tract infections [15]. men-
ingitis [1, 16], and abscesses [17, 18]. Severe disease with
bacteremia has been described in patients with predisposing
factors such as immunodeficiency [6, 19], malignancy [8],
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hepatobiliary disease [6, 8] and renal failure [13]. Only two
cases of arthritis and two cases of osteomyelitis and one case
of spondylodiscitis have been reported so far [13, 20].
Here, we report a wound infection caused by S. algae in a
healthy young man without any underlying diseases. The
source of organism that caused the cutaneous navel lesion was
likely to be the marine environment and the bacterium was
isolated in pure culture from the purulent discharge. To the
best of our knowledge, this is first case of wound infection
clearly caused by S. algae to be reported in Iran. In this region,
there has been only one more case of wound infection
reported in Turkey but the agent was shown to be S.
putrefaciens [21]. Commercial automated identification sys-
tems cannot distinguish S. algae from S. putrefaciens and,
therefore, it is possible that some of the isolates reported as S.
putrefaciens might in fact have belonged to the species S. algae
[1, 2]. In this regard we recommend that molecular techniques
such as 16S rRNA gene sequence analysis be used to confirm
identification of this bacterium, as has also been emphasized by
others [20].
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